Influence of gastrin on human astrocytic tumor cell proliferation

Journal of the National Cancer Institute

Volumn 88, Issue 9, 1996, Pages 594-600

  Camby, Isabelle ^a,e   Salmon, Isabelle ^b   Danguy, André ^a   Pasteels, Jean Lambert ^a   Brotchi, Jacques ^b   Martinez, Jean ^c   Kiss, Robert ^a,d,e  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c CNRS   (France)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

^e FNRS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; DEVAZEPIDE; GASTRIN; JMV 234; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA CELL; AUTORADIOGRAPHY; COLORIMETRY; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; TUMOR GROWTH;

AMINO ACID SEQUENCE; ASTROCYTOMA; AUTORADIOGRAPHY; BENZODIAZEPINONES; BRAIN NEOPLASMS; CELL DIVISION; CHOLECYSTOKININ; DEVAZEPIDE; GASTRINS; HORMONE ANTAGONISTS; HUMANS; INDOLES; MEGLUMINE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHENYLUREA COMPOUNDS; RECEPTORS, CHOLECYSTOKININ; SINCALIDE; THYMIDINE; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0029875160     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.9.594     Document Type: Article

References (50)

1. Coons SW, Johnson PC, Shapiro JR. Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. Cancer Res 1995;55:1569-77.
2. Karim AB, Laws ER, Glioma, principles and practice in neuro-oncology. Berlin and Heidelberg: Springer-Verlag, 1991.
3. Maria BL, Eskin TA, Quisling RG. Brainstem and other malignant gliomas: 11. Possible mechanisms of brain infiltration by tumor cells. J Child Neurol 1993;8:292-305.
4. Brandes A, Soesan M, Fiorentino MV. Medical treatment of high grade malignant gliomas in adults: an overview. Cancer Res 1991;51: 719-27.
5. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors [see comment citations in Medline]. Science 1992;256: 1550-2.
6. Jenks S. Dramatic new strategies for brain tumors emerge [news]. J Natl Cancer Inst 1992;84:662-3.
7. Mulshine JL, Shuke N, Daghighian F, Carrasquillo J, Ghosh B, Walsh T, et al. The correct dose: pharmacologically guided end point for anti-growth factor therapy. Cancer Res 1992;52(9 Suppl):2743s-2746s.
8. Courriere P, Tremoulet M, Eche N, Armand JP. Hormonal steroid receptors in intracranial tumours and their relevance in hormone therapy. Eur J Cancer Clin Oncol 1985;21: 711-4.
9. Rao BR, Roelvink CA, Slotman BJ. Role of steroid hormones in gliomas. In: Karim AB, Laws ER, editors. Glioma, principles and practice in neuro-oncology. Berlin and Heidelberg: Springer-Verlag, 1991:165-9.
10. Marushige Y, Raju NR, Marushige K, Koestner A. Modulation of growth and of morphological characteristics in glioma cells by nerve growth factor and glia maturation factor Cancer Res 1981;47:4109-15
11. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT. Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium. J Neurosurg 1990;73:106-12.
12. Maxwell M, Naber SP, Wolfe HJ, Hedley-Whyte ET, Galanopoulos T, Neville-Golden J, et al. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 1991;51:1345-51.
13. Torp SH, Helseth E, Dalen A, Unsgaard G. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother 1991;33:61-4.
14. Camby I, Salmon I, Rorive S, Gras T, Darro F, Kruczynski A, et al. Characterization of the influence of anti-hormone and/or growth factor neutralizing antibodies on cell clone architecture and the growth of human neoplastic astrocytic cell lines. J Neurconcol 1994;20:67-80.
15. Rehfeld JF, van Solinge WW. The tumor biology of gastrin and cholecystokinin. Adv Cancer Res 1994;63:295-347.
16. van Solinge WW, Odum L, Rehfeld JF. Ovarian cancers express and process progastrin. Cancer Res 1993;53:1823-8.
17. Sethi T, Rozengurt E. Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells. Cancer Res 1992;52:6031-5.
18. Seva C, Dickinson CJ, Yamada T. Growth-promoting effects of glycine-extended progastrin. Science 1994;265:410-2.
19. Hokfelt T, Cones R, Schalling M, Ceccatelli S, Pelto-Huikko M, Persson H, et al. Distribution patteras of CCK and CCK mRNA in some neuronal and non-neuronal tissues. Neuropeptides 1991;19:31-43.
20. Tamarelle M, Romeuf M, Vanderhaeghen JJ. Immunohistochemical localization of gastrin-cholecystokinin-like material in the central nervous system of the migratory locust. Histochemistry 1988;89:201-7.
21. Grimmelikhuijzen CJ, Sundler F, Rehfeld JF. Gastrin/CCK-like immunoreactivity in the nervous system of coelenterates. Histochemistry 1980;69:61-8.
22. Himick BA, Peter RE. CCK/gastrin-like immunoreactivity in brain and gut. and CCK suppression of feeding in goldfish. Am J Physiol 1994;267(3 Pt 2): R841-51.
23. Rehfeld JF. Progastrin and its products in the cerebellum. Neuropeptides 1991;20:239-45.
24. Vanderhaeghen JJ, Lotstra F, De Mey J, Gilles C. Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. Proc Natl Acad Sci U S A 1980;77:1190-4.
25. Rehfeld JF, Hansen HF. Characterization of preprocholecystokinin products in the porcine cerebral cortex. Evidence of different processing pathways. J Biol Chem 1986;261:5832-40.
26. Vanderhaeghen JJ, Goldman S, Lotstra F, Van Reeth O, Deschepper C, Rossier J, et al. Coexistence of cholecystokinin- or gastrin-like peptides with other peptides in the hypophysis and the hypothalamus. Ann N Y Acad Sci 1985;448:334-44.
27. Rehfeld JF, Hansen HF. Larsson LI, Stengaard-Pedersen K, Thorn NA. Gastrin and cholecystokinin in pituitary neurons. Proc Natl Acad Sci U S A 1984;81:1902-5.
28. Rehfeld JF, Kruse-Larsen C. Gastrin and cholecystokinin in human cerebrospinal fluid. Immunochemical determination of concentrations and molecular heterogeneity. Brain Res 1978;155:19-26.
29. Singh P, Xu Z, Dai B, Rajaraman S, Rubin N, Dhruva B. Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins. Am J Physiol 1994:266(3 Pt 1):G459-68.
30. Begos DG, Modlin IM. Gastrin and colon cancer: Clarifying the controversy [editorial]. J Clin Gastroenterol 1994;18:189-93.
31. Przedborski S, Goldman S, Schiffmann SN, Vierendeels G, Depierreux M, Levivier M, et al. Neuropeptide Y, somatostatin, and cholecystokinin neuron preservation in anaplastic astrocytomas. Acta Neuropathol 1988;76:507-10.
32. Bardram L. Progastrin in serum from Zollinger-Ellison patients. An indicator of malignancy? Gastroenterology 1990;98:1420-6.
33. Wank SA. Cholecystokinin receptors [editorial]. Am J Physiol 1995;269(5 Pt 1):G628-46.
34. Ito M, Matsui T, Taniguchi T, Tsukamoto T, Murayama T, Arima N, et al. Functional characterization of a human brain cholecystokininB receptor. A trophic effort of Cholecystokinin and gastrin. J Biol Chem 1993; 268:18300-5.
35. Smith JP, Fantaskey AP, Lui G, Zagon IS. Identification of gastrin as a growth peptide in human pancreatic cancer. Am J Physiol 1995; 268(1 Pt 2):R135-41.
36. Lotti VJ, Chang RS. A new potent and selective non-peptide gastrin antagonist and brain Cholecystokinin receptor (CCK-B) ligand: L-365.260. Eur J Pharmacol 1989;162:273-80.
37. Singh L, Field MJ, Hughes J, Menzies R, Oles RJ, Vass CA, et al. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist. Br J Pharmacol 1991;104:239-45.
38. Chang RS, Lotti VJ. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci U S A 1986;83:4923-6.
39. Jensen RT, Zhou ZC, Murphy RB, Jones SW, Setnikar I, Rovati LA, et al. Structural features of various proglumide-related cholecystokinin receptor antagonists. Am J Physiol 1986;251(6 Pt 1):G839-46.
40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
41. Pauwels O, Kiss R. Digital morphonuclear analyses of sensitive versus resistant neoplas-tic cells to vinca-alkaloid, alkylating, and intercalating drugs. Cytometry 1991;12:388-97.
42. Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, et al. Comparison of in vitro anticancer-drug-screening data generated with tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 1990;82: 1113-8.
43. Vistica DT, Skehan P, Scudiero DA, Monks A, Pittman A, Boyd MR. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production [published erratum appears in Cancer Res 1991;51:4501]. Cancer Res 1991;51: 2515-20.
44. Bhat NR, Hauser KF, Kindy MS. Cell proliferation and protooncogene induction in oligodendroglial progenitors. J Neurosci Res 1992;32:340-9.
45. Darro F, Kruczynski A, Etievant C, Martinez J, Pasteels JL, Kiss R. Characterization of the differentiation of human colorectal cancer cell lines by means of Voronoi diagrams. Cytometry 1993; 14:783-92.
46. de Launoit Y, Kiss R, Jossa V, Coibion M, Paridaens RJ, De Backer E, et al. Influence of dihydrotestosterone, testosterone, estradiol, progesterone, or prolactin on the cell kinetics of human hyperplastic prostatic tissue in organ culture. Prostate 1988;13:143-53.
47. Kleihues P, Burger PC, Scheithauer BW. Histological typing of the tumours of the central nervous system. World Health Organization. Berlin: Springer-Verlag, 1992.
48. Bold RJ, Alpard S, Ishizuka J, Townsend CM Jr, Thompson JC. Growth-regulatory effect of gastrin on human colon cancer cell lines is determined by protein kinase a isoform content. Regul Pept 1994;53:61-70.
49. Kiss R, Salmon I, Pauwels O, Gras S, Danguy A, Etievant C, et al. In vitro influence of gastrin, oestradiol and gonadotropin-releasing hormone on HCT-15 and LoVo human colorectal neoplastic cell proliferation. Eur J Cancer 1991;27:1268-74.
50. Kiss R, de Launoit Y, Danguy A, Paridaens R, Pasteels JL. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors. Cancer Res 1989;49:2945-51.